Zim Laboratories Limited has initiated a postal ballot process to seek shareholder approval for revising the remuneration structure of its Managing Director and Whole-Time Director. The company is proposing a revision in the pay packages of Dr. Anwar Daud, Managing Director, and Mr. Zulfiquar Kamal, Whole-Time Director, which includes an increase in fixed remuneration and performance-linked incentives. The resolutions require shareholder consent via remote e-voting, which is scheduled to take place from July 13, 2026, to August 11, 2026.

The special resolutions propose a fixed remuneration of up to ₹3.00 crore per annum for Dr. Anwar Daud and up to ₹2.50 crore per annum for Mr. Zulfiquar Kamal. Additionally, the Managing Director is eligible for a Performance Linked Incentive (PLI) of up to 42.50% of the aggregate fixed salary, while the Whole-Time Director is eligible for a PLI of up to 25% of the aggregate fixed salary. These revisions are proposed to be effective until the expiry of their current terms, which are July 30, 2027, and October 18, 2027, respectively.

Remuneration Details

The following table outlines the proposed remuneration structure for the directors:

The company states that the revisions are intended to simplify the remuneration structure by removing lower limits while retaining the maximum limits. The Nomination and Remuneration Committee and the Board of Directors have approved the revised methodology for determining the performance-linked incentives to ensure greater consistency and transparency. All other terms and conditions governing their remuneration will remain unchanged as approved by members at the Extraordinary General Meeting held on June 29, 2022.

Voting Process and Timelines

The remote e-voting period commences at 9:00 a.m. IST on July 13, 2026, and concludes at 5:00 p.m. IST on August 11, 2026. The facility is being provided by National Securities Depository Limited (NSDL). Members whose names appear in the Register of Members or Register of Beneficial Owners as on July 3, 2026, the cut-off date, are eligible to vote. The notice has been dispatched electronically to members, and physical ballot forms will not be accepted.

Ms. Roshni Jethani, a Practicing Company Secretary, has been appointed as the Scrutinizer to oversee the postal ballot process. The results of the voting will be announced on or before August 13, 2026. The resolutions, if passed by the requisite majority, will be deemed to have been passed on the last date of e-voting, August 11, 2026. The company will intimate the results to BSE Limited and National Stock Exchange of India Limited and upload them to its website.

Zim Laboratories Ltd has scheduled a meeting with investors and analysts for July 3, 2026. The company will hold a one-on-one session with Canara HSBC Life Insurance to discuss business matters. The meeting is scheduled to take place in person, providing an opportunity for direct engagement with the fund manager.

The disclosure was made in compliance with Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The company confirmed that no unpublished price sensitive information (UPSI) will be shared during the aforesaid meeting. The schedule remains subject to change due to exigencies.

Meeting Schedule

The communication was addressed to the stock exchanges, including BSE Limited and National Stock Exchange of India Limited, to keep the intimation on record.